Skip to main content

Multiple Risk Factors in Cardiovascular Disease

Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke

  • Book
  • © 1998

Overview

Part of the book series: Medical Science Symposia Series (MSSS, volume 12)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (40 chapters)

  1. Diabetes

  2. Genetic Determinants of Cardiovascular Disease

  3. Inflammation and Cardiovascular Disease

  4. From Cholesterol to Cardiovascular Events, Where is the Bridge?

  5. Lifestyle and Cardiovascular Disease

  6. Multiple Risk Factors and Cardiovascular Disease

Keywords

About this book

This volume is a collection of the most significant contributions to the 4th International Symposium on MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE: STRATEGIES OF PREVENTION OF CORONARY HEART DISEASE, CARDIAC F AlLURE, AND STROKE held in Washington, D. C. in April 1997. The meeting focused on the risk factors for cardiovascular disease and their interactions. The need for this symposium is based on the epidemiological, clinical, and biological evidence that individuals from industrialized countries often possess two or more risk factors which synergistically increase the global risk profile. This has become more evident in recent years with the increase in life expectancy of populations in the industrialized countries. The evidence that a combination of risk factors confers a very high risk of developing cardiovascular diseases, is of pivotal interest in the process of detection of patients who will benefit the most from pharmacological treatment. Many recent epidemiological data identifying the intrinsic and environmental factors contributing to the development of atherosclerosis are discussed. These results, in parallel with basic and clinical research, underline atherosclerosis as a complex and multifactorial process involving the influences of lipids, including lipoprotein subfractions, blood pressure rheologic forces, carbohydrate tolerance, and thrombogenic factors, including fibrinogen, tissue factor, PAl-I, and homocysteine. Furthennore, the risk associated with anyone of these risk factors varies widely depending on the level of the associated atherogenic risk factors. Hyper­ cholesterolemia and hypertriglyceridemia, for instance, are more common than would be expected by chance among hypertensive patients.

Editors and Affiliations

  • Cornell University Medical College, New York, USA

    Antonio M. Gotto

  • National Heart, Lung, and Blood Institute, NIH, Bethesda, USA

    C. Lenfant

  • Institute of Pharmacological Sciences, University of Milan, Milan, Italy

    Rodolfo Paoletti, A. L. Catapano

  • Giovanni Lorenzini Medical Foundation, Houston, USA

    A. S. Jackson

Bibliographic Information

  • Book Title: Multiple Risk Factors in Cardiovascular Disease

  • Book Subtitle: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke

  • Editors: Antonio M. Gotto, C. Lenfant, Rodolfo Paoletti, A. L. Catapano, A. S. Jackson

  • Series Title: Medical Science Symposia Series

  • DOI: https://doi.org/10.1007/978-94-011-5022-4

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 1998

  • Hardcover ISBN: 978-0-7923-5023-1Published: 31 March 1998

  • Softcover ISBN: 978-94-010-6108-7Published: 05 November 2012

  • eBook ISBN: 978-94-011-5022-4Published: 06 December 2012

  • Series ISSN: 0928-9550

  • Edition Number: 1

  • Number of Pages: XVII, 371

  • Topics: Cardiology, Diabetes

  • Industry Sectors: Biotechnology, Engineering, Finance, Business & Banking, Health & Hospitals, Pharma

Publish with us